Logo image of UCL

UCLOUDLINK GROUP INC (UCL) Stock Fundamental Analysis

NASDAQ:UCL - Nasdaq - US90354D1046 - ADR - Currency: USD

1.83  0 (0%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to UCL. UCL was compared to 21 industry peers in the Wireless Telecommunication Services industry. UCL has only an average score on both its financial health and profitability. UCL does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

5

1. Profitability

1.1 Basic Checks

In the past year UCL was profitable.
UCL had a positive operating cash flow in the past year.
In multiple years UCL reported negative net income over the last 5 years.
In multiple years UCL reported negative operating cash flow during the last 5 years.
UCL Yearly Net Income VS EBIT VS OCF VS FCFUCL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 -20M -40M -60M

1.2 Ratios

UCL's Return On Assets of 5.60% is amongst the best of the industry. UCL outperforms 85.71% of its industry peers.
UCL has a Return On Equity of 16.48%. This is amongst the best in the industry. UCL outperforms 80.95% of its industry peers.
UCL has a Return On Invested Capital of 8.96%. This is in the better half of the industry: UCL outperforms 71.43% of its industry peers.
Industry RankSector Rank
ROA 5.6%
ROE 16.48%
ROIC 8.96%
ROA(3y)-10.45%
ROA(5y)-33.28%
ROE(3y)-58.54%
ROE(5y)-103.86%
ROIC(3y)N/A
ROIC(5y)N/A
UCL Yearly ROA, ROE, ROICUCL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 200 -200

1.3 Margins

With a Profit Margin value of 3.81%, UCL perfoms like the industry average, outperforming 57.14% of the companies in the same industry.
UCL's Profit Margin has improved in the last couple of years.
UCL has a Operating Margin (3.69%) which is comparable to the rest of the industry.
In the last couple of years the Operating Margin of UCL has declined.
With a Gross Margin value of 47.75%, UCL is not doing good in the industry: 61.90% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of UCL has grown nicely.
Industry RankSector Rank
OM 3.69%
PM (TTM) 3.81%
GM 47.75%
OM growth 3YN/A
OM growth 5Y-2.15%
PM growth 3YN/A
PM growth 5Y26.84%
GM growth 3Y17.9%
GM growth 5Y3.39%
UCL Yearly Profit, Operating, Gross MarginsUCL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 -60

More info and screens

5

2. Health

2.1 Basic Checks

UCL has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, UCL has more shares outstanding
Compared to 5 years ago, UCL has more shares outstanding
The debt/assets ratio for UCL is higher compared to a year ago.
UCL Yearly Shares OutstandingUCL Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
UCL Yearly Total Debt VS Total AssetsUCL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

UCL has an Altman-Z score of -2.06. This is a bad value and indicates that UCL is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of UCL (-2.06) is worse than 90.48% of its industry peers.
The Debt to FCF ratio of UCL is 1.06, which is an excellent value as it means it would take UCL, only 1.06 years of fcf income to pay off all of its debts.
UCL has a better Debt to FCF ratio (1.06) than 95.24% of its industry peers.
A Debt/Equity ratio of 0.37 indicates that UCL is not too dependend on debt financing.
UCL's Debt to Equity ratio of 0.37 is amongst the best of the industry. UCL outperforms 85.71% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.37
Debt/FCF 1.06
Altman-Z -2.06
ROIC/WACC1.06
WACC8.46%
UCL Yearly LT Debt VS Equity VS FCFUCL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M

2.3 Liquidity

UCL has a Current Ratio of 1.34. This is a normal value and indicates that UCL is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Current ratio value of 1.34, UCL is doing good in the industry, outperforming 61.90% of the companies in the same industry.
UCL has a Quick Ratio of 1.28. This is a normal value and indicates that UCL is financially healthy and should not expect problems in meeting its short term obligations.
UCL has a better Quick ratio (1.28) than 61.90% of its industry peers.
Industry RankSector Rank
Current Ratio 1.34
Quick Ratio 1.28
UCL Yearly Current Assets VS Current LiabilitesUCL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

More info and screens

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 200.00% over the past year.
UCL shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 3.89% yearly.
Looking at the last year, UCL shows a small growth in Revenue. The Revenue has grown by 7.65% in the last year.
UCL shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -10.37% yearly.
EPS 1Y (TTM)200%
EPS 3YN/A
EPS 5Y3.89%
EPS Q2Q%-300%
Revenue 1Y (TTM)7.65%
Revenue growth 3Y7.48%
Revenue growth 5Y-10.37%
Sales Q2Q%3.43%

3.2 Future

UCL is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -49.75% yearly.
Based on estimates for the next years, UCL will show a small growth in Revenue. The Revenue will grow by 6.48% on average per year.
EPS Next Y-91.58%
EPS Next 2Y-49.75%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year5.96%
Revenue Next 2Y6.48%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
UCL Yearly Revenue VS EstimatesUCL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 50M 100M 150M
UCL Yearly EPS VS EstimatesUCL Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 0 -0.5 -1

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 20.33, the valuation of UCL can be described as rather expensive.
UCL's Price/Earnings ratio is a bit cheaper when compared to the industry. UCL is cheaper than 61.90% of the companies in the same industry.
UCL is valuated rather cheaply when we compare the Price/Earnings ratio to 27.45, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 60.40, UCL can be considered very expensive at the moment.
Based on the Price/Forward Earnings ratio, UCL is valued expensively inside the industry as 80.95% of the companies are valued cheaper.
UCL's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 21.89.
Industry RankSector Rank
PE 20.33
Fwd PE 60.4
UCL Price Earnings VS Forward Price EarningsUCL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, UCL is valued cheaper than 85.71% of the companies in the same industry.
The rest of the industry has a similar Price/Free Cash Flow ratio as UCL.
Industry RankSector Rank
P/FCF 9.2
EV/EBITDA 3.81
UCL Per share dataUCL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1 1.5 2

4.3 Compensation for Growth

UCL's earnings are expected to decrease with -49.75% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)5.23
EPS Next 2Y-49.75%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

UCL does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

UCLOUDLINK GROUP INC

NASDAQ:UCL (7/3/2025, 8:14:40 PM)

1.83

0 (0%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupTelecommunication Services
GICS IndustryWireless Telecommunication Services
Earnings (Last)05-21 2025-05-21/bmo
Earnings (Next)08-11 2025-08-11
Inst Owners17.57%
Inst Owner Change-100%
Ins Owners8.51%
Ins Owner ChangeN/A
Market Cap68.87M
Analysts80
Price Target9.18 (401.64%)
Short Float %0.48%
Short Ratio0.17
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-320.79%
Min EPS beat(2)-692.08%
Max EPS beat(2)50.5%
EPS beat(4)3
Avg EPS beat(4)-61.88%
Min EPS beat(4)-692.08%
Max EPS beat(4)296.04%
EPS beat(8)5
Avg EPS beat(8)-31.19%
EPS beat(12)7
Avg EPS beat(12)-6.79%
EPS beat(16)9
Avg EPS beat(16)-86.94%
Revenue beat(2)2
Avg Revenue beat(2)2.1%
Min Revenue beat(2)2%
Max Revenue beat(2)2.2%
Revenue beat(4)3
Avg Revenue beat(4)0.14%
Min Revenue beat(4)-4.25%
Max Revenue beat(4)2.2%
Revenue beat(8)5
Avg Revenue beat(8)-1.13%
Revenue beat(12)6
Avg Revenue beat(12)-1.13%
Revenue beat(16)8
Avg Revenue beat(16)-0.79%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)100%
EPS NY rev (1m)116.67%
EPS NY rev (3m)116.67%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)2.22%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.1%
Valuation
Industry RankSector Rank
PE 20.33
Fwd PE 60.4
P/S 0.75
P/FCF 9.2
P/OCF 9.2
P/B 3.23
P/tB 3.3
EV/EBITDA 3.81
EPS(TTM)0.09
EY4.92%
EPS(NY)0.03
Fwd EY1.66%
FCF(TTM)0.2
FCFY10.87%
OCF(TTM)0.2
OCFY10.87%
SpS2.45
BVpS0.57
TBVpS0.55
PEG (NY)N/A
PEG (5Y)5.23
Profitability
Industry RankSector Rank
ROA 5.6%
ROE 16.48%
ROCE 15.43%
ROIC 8.96%
ROICexc N/A
ROICexgc N/A
OM 3.69%
PM (TTM) 3.81%
GM 47.75%
FCFM 8.11%
ROA(3y)-10.45%
ROA(5y)-33.28%
ROE(3y)-58.54%
ROE(5y)-103.86%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5Y-2.15%
PM growth 3YN/A
PM growth 5Y26.84%
GM growth 3Y17.9%
GM growth 5Y3.39%
F-Score6
Asset Turnover1.47
Health
Industry RankSector Rank
Debt/Equity 0.37
Debt/FCF 1.06
Debt/EBITDA 1.39
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 250
Cash Conversion 130.59%
Profit Quality 212.95%
Current Ratio 1.34
Quick Ratio 1.28
Altman-Z -2.06
F-Score6
WACC8.46%
ROIC/WACC1.06
Cap/Depr(3y)133.27%
Cap/Depr(5y)103.42%
Cap/Sales(3y)2.46%
Cap/Sales(5y)2.1%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)200%
EPS 3YN/A
EPS 5Y3.89%
EPS Q2Q%-300%
EPS Next Y-91.58%
EPS Next 2Y-49.75%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)7.65%
Revenue growth 3Y7.48%
Revenue growth 5Y-10.37%
Sales Q2Q%3.43%
Revenue Next Year5.96%
Revenue Next 2Y6.48%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y229.65%
EBIT growth 3YN/A
EBIT growth 5Y-12.3%
EBIT Next Year25.81%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-28.6%
FCF growth 3YN/A
FCF growth 5Y12.11%
OCF growth 1Y-28.6%
OCF growth 3YN/A
OCF growth 5Y9.78%